Astrazeneca (AZN) Income from Non-Controlling Interests (2009 - 2026)
Astrazeneca's Income from Non-Controlling Interests was $1 million in Q2 2026, compared with -$2 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Income from Non-Controlling Interests was -$821 million through Jun 30, 2026; for FY2025, it was $8 million, up 33.3% from FY2024.
- In earlier years, Income from Non-Controlling Interests was $6 million in FY2024 (unchanged), $6 million in FY2023 (+20.0%), $5 million in FY2022 (+66.7%) and $3 million in FY2021.
- Quarterly Income from Non-Controlling Interests has moved between -$825 million (Q4 2025) and $360 million (Q2 2022) over five years.
- Compared with a year earlier, Income from Non-Controlling Interests was higher in 1 of the last four quarters, with growth averaging 67.5%.
- The best year-over-year quarter for Income from Non-Controlling Interests over five years was Q1 2025 (growth of 400.0%); the worst was Q2 2023 (a decline of 99.4%).
- Per Business Quant data, AZN's Income from Non-Controlling Interests in the three quarters before Q2 2026 was $1 million (Q1 2026), -$825 million (Q4 2025) and $2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | -825.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 360.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
API Access
Astrazeneca Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();